Sex: F
Vaccine: COVID19
Symptoms: Injection site mass, Injection site pruritus, Injection site swelling, Pyrexia
Clinical narrative: Fever; Lump, swelling, itchiness at the injection site; Lump, swelling, itchiness at the injection site; Injection site swelling; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), INJECTION SITE MASS (Lump, swelling, itchiness at the injection site), INJECTION SITE PRURITUS (Lump, swelling, itchiness at the injection site) and INJECTION SITE SWELLING (Injection site swelling) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.     On 14-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced PYREXIA (Fever), INJECTION SITE MASS (Lump, swelling, itchiness at the injection site), INJECTION SITE PRURITUS (Lump, swelling, itchiness at the injection site) and INJECTION SITE SWELLING (Injection site swelling). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of Cream. At the time of the report, PYREXIA (Fever), INJECTION SITE MASS (Lump, swelling, itchiness at the injection site), INJECTION SITE PRURITUS (Lump, swelling, itchiness at the injection site) and INJECTION SITE SWELLING (Injection site swelling) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Jan-2021 and was forwarded to Moderna on 22-Jan-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), INJECTION SITE MASS (Lump, swelling, itchiness at the injection site), INJECTION SITE PRURITUS (Lump, swelling, itchiness at the injection site) and INJECTION SITE SWELLING (Injection site swelling) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.     On 14-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced PYREXIA (Fever), INJECTION SITE MASS (Lump, swelling, itchiness at the injection site), INJECTION SITE PRURITUS (Lump, swelling, itchiness at the injection site) and INJECTION SITE SWELLING (Injection site swelling). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of Cream. At the time of the report, PYREXIA (Fever), INJECTION SITE MASS (Lump, swelling, itchiness at the injection site), INJECTION SITE PRURITUS (Lump, swelling, itchiness at the injection site) and INJECTION SITE SWELLING (Injection site swelling) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.